Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Bonavaud, S.
	Articles by Barlovatz-Meimon, G.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Bonavaud, S.
	Articles by Barlovatz-Meimon, G.

Adams, J. C. and Watt, F. M (1993). Regulation of development and differentiation by the extracellular matrix. Development 117, 1183-1198.[Medline]

Andreasen, P. A., Georg, B., Lund, L. R., Riccio, A. and Stacey, S. N (1990). Plasminogen activator inhibitors: hormonally regulated serpins. Mol. Cell Endocrinol 68, 1-19.[Medline]

Apella, E., Robinson, E. A., Ulrich, S. J., Stopelli, M. P., Corti, A., Cassani, G. and Blasi, F (1987). The receptor binding sequence of urokinase-biological function for the growth factor module proteases. J. Biol. Chem 262, 4437-4440.[Abstract/Free Full Text]

Behrendt, N., R\277nne, E., Ploug, M., Petri, T., L\277ber, D., Nielsen, L. S., Schleuning, W. D., Blasi, F., Appella, E. and Dan\277, K (1990). The human receptor for urokinase plasminogen activator. NH2 terminal amino acid sequence and glycosylation variants. J. Biol. Chem 265, 6453-6460.[Abstract/Free Full Text]

Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L. and Weintraub, H (1990). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59.[Medline]

Blasi, F (1993). Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. BioEssays 152, 105-111.

Breton, M., Li, Z. L., Paulin, D., Harris, J., Rieger, F., Pin\215on-Raymond, M. and Garcia, L (1995). Myotube driven myogenic recruitment of cells during in vitro myogenesis. Dev. Dynam 202, 126-136.[Medline]

Busso, N., Masur, S. K., Lazega, D., Waxman, S. and Ossowski, L (1994). Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol 126, 259-270.[Abstract/Free Full Text]

Chomczynski, P. and Sacchi, N (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem 162, 156-159.[Medline]

Conese, M., Nykjaer, A., Petersen, C. M., Cremona, O., Pardi, R., Andreasen, P. A., Gliemann, J., Christensen, E. I. and Blasi, F (1995). Alpha-(2) macroglobulin receptor LDL-receptor-related protein (LRP)-dependent internalization of the urokinase receptor. J. Cell Biol 131, 1609-1622.[Abstract/Free Full Text]

Cubellis, M. V., Wun, T. and Blasi, F (1990). Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9, 1079-1085.[Medline]

DiMilla, P. A., Stone, J. A., Quinn, J. A., Albelda, S. M. and Lauffenburger, D. A (1993). An optimal adhesiveness exists for human smooth muscle cell migration on type IV collagen and fibronectin. J. Cell Biol 122, 729-737.[Abstract/Free Full Text]

Drapier, J. C., Tenu, J. P., Lemaire, G. and Petit, J. F (1979). Regulation of plasminogen activator secretion in mouse peritoneal macrophages \320 I) Role of serum studied by a new spectrophotometric assay for plasminogen activators. Biochimie 61, 463-471.[Medline]

Dumler, I., Petri, T. and Schleuning, W. D (1993). Interaction of urokinase-type plasminogen activator uPA with its cellular receptor uPAR induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett 3221, 37-40.

Ellis, V., Wun, T. C., Behrendt, N., R\277nne, E. and Dan\277, K (1990). Inhibition of receptor-bound urokinase by plasminogen activitor inhibitors. J. Biol. Chem 265, 9904-9908.[Abstract/Free Full Text]

Estreicher, A., Mulhauser, J., Carpentier, J. L., Orci, L. and Vassalli, J. D (1990). The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol 111, 783-792.[Abstract/Free Full Text]

Fazioli, F. and Blasi, F (1994). Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?. Trends Pharmacol. Sci 15, 25-29.[Medline]

Ferguson, M. A. and Williams, A. F (1988). Cell-surface anchoring of proteins via glycosylphosphatidylinositol structures. Annu. Rev. Biochem 57, 285-320.[Medline]

Gold, L., Rostagno, A., Frangione, B. and Passalaris, T (1992). Localization of the cleavage sites on fibronectin following digestion by urokinase. J. Cell. Biochem 50, 441-452.[Medline]

Gyetko, M. R., Todd, R. F. III, Wilkinson, C. C. and Sitrin, R. G (1996). The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest 93, 1380-1387.

Ingber, D (1993). Cellular tensegrity: defining new rules of biological design that govern the cytoskeleton. J. Cell Sci 104, 613-627.[Medline]

Kanse, S. M., Kost, C., Wilhelm, O. G., Andreasen, P. A. and Preissner, K.T (1996). The urokinase receptors is a major vitronectin-binding protein on endothelial cells. Exp. Cell Res 224, 344-353.[Medline]

Kindzelskii, A. L., Laska, Z. O., Todd, R. F. and Petty, H. R (1996). Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha(M)beta(2)CD11B/CD18) during neutrophil polarization. J. Immunol 156, 297-309.[Abstract]

Lagord, C., Carpentier, G., Moraczewski, J., Pons, G., Climent, F. and Martelly, I (1993). Satellite cell myogenesis is highly stimulated by the kinase inhibitor iso-H7: comparison with HA1004 and staurosporine effects. Biochem. Biophys. Res. Commun 191, 928-936.[Medline]

Lauffenburger, D. A. and Horwitz, A. F (1996). Cell migration: a physically integrated molecular process. Cell 84, 359-369.[Medline]

Lazarides, E. and Hubbard, B. D (1976). Immunological characterization of the subunit of the 100 \201 filaments from muscle cells. Proc. Nat. Acad. Sci. USA 73, 4344-4348.[Abstract/Free Full Text]

Le Moigne, A., Martelly, I., Barlovatz-Meimon, G., Franquinet, R., Aamiri, A., Frisdal, E., Bassaglia, Y., Moraczewski, J. and Gautron, J (1990). Characterization of myogenesis from adult satellite cells cultured in vitro. Int. J. Dev. Biol 34, 171-180.[Medline]

Lowry, O., Rosebrough, N., Farr, A. and Randall, R (1951). Protein measurement with folin reagent. J. Biol. Chem 193, 265-275.[Free Full Text]

Meissauer, A., Kramer, M. D., Hofmann, M., Erkell, L. J., Jacob, E., Schirrmacher, V. and Brunner G (1991). Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells. Exp. Cell Res 192, 453-459.[Medline]

Mignatti, P., Robbins, E. and Rifkins, D. B (1986). Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47, 487-498.[Medline]

Mimuro, J., Kaneko, M., Murakami, T., Matsuda, M. and Sakata, Y (1992). Reversible interactions between plasminogen activators and plasminogen activator inhibitor-1. Biochim. Biophys. Acta 1160, 325-334.[Medline]

Nameroff, M. and Munar, E (1976). Inhibition of cellular differentiation by phospholipase C. Dev. Biol 49, 288-293.[Medline]

Nykjaer, A., M\277ller, B., Todd, R. F. III, Christensen, T., Andreasen, P. A., Gliemann, J. and Munck Petersen, C (1994). Urokinase receptor \320 An activation antigen in human T lymphocytes. J. Immunol 152, 505-516.[Abstract]

Ossowski, L. and Reich, E (1983). Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35, 611-619.[Medline]

Ossowski, L (1988). In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface bound urokinase. J. Cell Biol 107, 2437-2445.[Abstract/Free Full Text]

Pepper, M. S. and Montesano, R (1991). Proteolytic balance and capillary morphogenesis. Cell Diff. Dev 32, 319-328.

Ploug, M., R\277nne, E., Behrendt, N., Jensen, A. L. and Blasi, F (1991). Cellular receptor for urokinase plasminogen activator: carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem 266, 1926-1933.[Abstract/Free Full Text]

P\232ll\212nen, J., Saksela, O., Salonen, E. M., Andreasen, P., Nielsen, L., Dan\277, K. and Vaheri, A (1987). Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J. Cell Biol 104, 1085-1096.[Abstract/Free Full Text]

P\232ll\212nen, J., Stephens, R. W. and Vaheri, A (1991). Directed plasminogen activation at the surface of normal and malignant cells. Advan. Cancer Res 57, 273-328.[Medline]

Quax, P. H. A., Frisdal, E., Pedersen, N., Bonavaud, S., Thibert, P., Martelly, I., Verheijen, J. H., Blasi, F. and Barlovatz-Meimon, G (1992). Modulation of activities and RNA level of the components of the plasminogen activation system during fusion of human myogenic satellite cells in vitro. Dev. Biol 151, 166-175.[Medline]

Quigley, J. P., Gold, L. I., Schwimmer, R. and Sullivan, L. M (1987). Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells. Proc. Nat. Acad. Sci. USA 84, 2776-2780.[Abstract/Free Full Text]

Quigley, J. P., Berkenpas, M. B., Aimes, R. T. and Chen, J. M (1990). Serine protease and metallo protease cascade systems involved in pericellular proteolysis. Cell Diff. Dev 32, 263-276.[Medline]

Ragno, P., Montuori, N., Vassalli, J. D. and Rossi, G (1993). Processing of the complex between urokinase and its type-2 inhibitor on the cell surface. FEBS Lett 323, 279-284.[Medline]

Resnati, M., Guttinger, M., Valcamonica, S., Sidenius, N., Blasi, F. and Fazioli, F (1996). Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J 15, 1572-1582.[Medline]

Rudnicki, M. A. and Jaenisch, R (1995). The MyoD family of transcription factors and skeletal myogenesis. BioEssays 17, 203-209.[Medline]

Seebacher, T., Manske, M., Zoller, J., Crabb, J. and Bade, E. G (1992). The EGF-inducible protein EIP-1 of migrating normal and malignant rat liver epithelial cells is identical to plasminogen activator inhibitor 1 and is a component of the ECM migration tracks. Exp. Cell Res 203, 504-507.[Medline]

Seiffert, D., Mimuro, J., Schleef, R. R. and Loskutoff, D. J (1990). Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin. Cell Diff Dev 32, 287-292.[Medline]

Stahl, A. and Mueller, B (1994). Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 54, 3066-3071.[Abstract/Free Full Text]

Stopelli, M. P., Corti, A., Soffientini, A., Cassani, G., Blasi, F. and Assoian, R. K (1985). Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Nat. Acad. Sci. USA 82, 4939-4943.[Abstract/Free Full Text]

Stopelli, M. P., Tacchetti, C., Cubellis, M. V., Corti, A., Hearing, V. J., Cassani, G., Appella, E. and Blasi, F (1986). Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell 45, 675-684.[Medline]

Sumiyoshi, K., Baba, S., Sakagushi, S., Urano, T., Takada, Y. and Takada, A (1991). Increase in levels of plasminogen activator and type 1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis. Thromb. Res 63, 59-71.[Medline]

Waltz, D. A. and Chapman, H. A (1994). Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem 269, 14746-14750.[Abstract/Free Full Text]

Watt, D., Karasinski, J., Moss, J. and England, M (1994). Migration of muscle cells. Nature 368, 406-407.[Medline]

Wright, W. E., Sassoon, D. A. and Lin, V. K (1989). Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56, 607-617.[Medline]

This article has been cited by other articles:

D. M. DiPasquale, M. Cheng, W. Billich, S. A. Huang, N. van Rooijen, T. A. Hornberger, and T. J. Koh
Urokinase-type plasminogen activator and macrophages are required for skeletal muscle hypertrophy in mice
Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1278 - C1285.
[Abstract] [Full Text] [PDF]

S. C. Bryer and T. J. Koh
The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1152 - R1158.
[Abstract] [Full Text] [PDF]

R. S. O'Connor, S. T. Mills, K. A. Jones, S. N. Ho, and G. K. Pavlath
A combinatorial role for NFAT5 in both myoblast migration and differentiation during skeletal muscle myogenesis
J. Cell Sci., January 1, 2007; 120(1): 149 - 159.
[Abstract] [Full Text] [PDF]

F. Maquerlot, S. Galiacy, M. Malo, C. Guignabert, D. A. Lawrence, M.-P. d'Ortho, and G. Barlovatz-Meimon
Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing
Am. J. Pathol., November 1, 2006; 169(5): 1624 - 1632.
[Abstract] [Full Text] [PDF]

T. J. Koh, S. C. Bryer, A. M. Pucci, and T. H. Sisson
Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration
Am J Physiol Cell Physiol, July 1, 2005; 289(1): C217 - C223.
[Abstract] [Full Text] [PDF]

H. Wang, L. Yang, Md. S. Jamaluddin, and D. D. Boyd
The Kruppel-like KLF4 Transcription Factor, a Novel Regulator of Urokinase Receptor Expression, Drives Synthesis of This Binding Site in Colonic Crypt Luminal Surface Epithelial Cells
J. Biol. Chem., May 21, 2004; 279(21): 22674 - 22683.
[Abstract] [Full Text] [PDF]

A. E. Barani, A.-C. Durieux, O. Sabido, and D. Freyssenet
Age-related changes in the mitotic and metabolic characteristics of muscle-derived cells
J Appl Physiol, November 1, 2003; 95(5): 2089 - 2098.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Bonavaud, S.

Articles by Barlovatz-Meimon, G.

Search for Related Content

PubMed

PubMed Citation

Articles by Bonavaud, S.

Articles by Barlovatz-Meimon, G.

				S. C. Bryer and T. J. Koh The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1152 - R1158. [Abstract] [Full Text] [PDF]

				R. S. O'Connor, S. T. Mills, K. A. Jones, S. N. Ho, and G. K. Pavlath A combinatorial role for NFAT5 in both myoblast migration and differentiation during skeletal muscle myogenesis J. Cell Sci., January 1, 2007; 120(1): 149 - 159. [Abstract] [Full Text] [PDF]

				F. Maquerlot, S. Galiacy, M. Malo, C. Guignabert, D. A. Lawrence, M.-P. d'Ortho, and G. Barlovatz-Meimon Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing Am. J. Pathol., November 1, 2006; 169(5): 1624 - 1632. [Abstract] [Full Text] [PDF]

				T. J. Koh, S. C. Bryer, A. M. Pucci, and T. H. Sisson Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration Am J Physiol Cell Physiol, July 1, 2005; 289(1): C217 - C223. [Abstract] [Full Text] [PDF]

				H. Wang, L. Yang, Md. S. Jamaluddin, and D. D. Boyd The Kruppel-like KLF4 Transcription Factor, a Novel Regulator of Urokinase Receptor Expression, Drives Synthesis of This Binding Site in Colonic Crypt Luminal Surface Epithelial Cells J. Biol. Chem., May 21, 2004; 279(21): 22674 - 22683. [Abstract] [Full Text] [PDF]

				A. E. Barani, A.-C. Durieux, O. Sabido, and D. Freyssenet Age-related changes in the mitotic and metabolic characteristics of muscle-derived cells J Appl Physiol, November 1, 2003; 95(5): 2089 - 2098. [Abstract] [Full Text] [PDF]